Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2018

Open Access 01-12-2018 | Research article

Cytochrome P450 family 4 subfamily F member 2 (CYP4F2) rs1558139, rs2108622 polymorphisms and susceptibility to several cardiovascular and cerebrovascular diseases

Authors: Tao Zhang, Kuiying Yu, Xuhua Li

Published in: BMC Cardiovascular Disorders | Issue 1/2018

Login to get access

Abstract

Background

Inconsistent conclusions have been reported for the genetic relationship between CYP4F2 (Cytochrome P450 Family 4 Subfamily F Member 2) polymorphisms and the susceptibility to cardiovascular and cerebrovascular diseases.

Methods

We performed a meta-analysis to assess the potential role of rs1558139 C/T and rs2108622 G/A polymorphisms of CYP4F2 in the risks of cardiovascular and cerebrovascular diseases. The retrieval of four databases, including PubMed, Web of Science (WOS), China National Knowledge Infrastructure (CNKI) and WANFANG DATA, was conducted. Mantel-Haenszel statistics for association test, Cochran’s Q statistic, sensitivity analysis for heterogeneity assessment, and Begg’s/Egger’s tests for publication bias evaluation were performed under allele, homozygote, heterozygote, dominant, and recessive models, respectively.

Results

A total of 597 articles were initially obtained by database searching, and twenty eligible articles were finally included. For rs1558139, a decreased risk of cardiovascular and cerebrovascular diseases was observed in the overall meta-analysis and in “hypertension”, “population-based” and “male” subgroups under models of T vs. C, CT vs. CC, and CT + TT vs. CC [all P values in association tests < 0.05, odds ratio (OR) < 1]. For rs2108622, a decreased coronary artery disease (CAD) risk was observed in the subgroup meta-analysis based on disease type under all genetic models (all P values in association tests < 0.05, OR< 1). Begg’s/Egger’s tests excluded the potential publication bias, while sensitivity analysis data supported the stability of the above results.

Conclusion

C/T genotype of CYP4AF2 rs1558139 may be linked to the decreased risk of hypertension in the male patients of Asian populations, while CYP4F2 rs2108622 is likely associated with reduced susceptibility to CAD.
Appendix
Available only for authorised users
Literature
1.
go back to reference Koberle B, Koch B, Fischer BM, Hartwig A. Single nucleotide polymorphisms in DNA repair genes and putative cancer risk. Arch Toxicol. 2016;90(10):2369–88.CrossRefPubMed Koberle B, Koch B, Fischer BM, Hartwig A. Single nucleotide polymorphisms in DNA repair genes and putative cancer risk. Arch Toxicol. 2016;90(10):2369–88.CrossRefPubMed
2.
go back to reference Srinivasan S, Clements JA, Batra J. Single nucleotide polymorphisms in clinics: fantasy or reality for cancer? Crit Rev Clin Lab Sci. 2016;53(1):29–39.CrossRefPubMed Srinivasan S, Clements JA, Batra J. Single nucleotide polymorphisms in clinics: fantasy or reality for cancer? Crit Rev Clin Lab Sci. 2016;53(1):29–39.CrossRefPubMed
5.
go back to reference van der Harst P, de Windt LJ, Chambers JC. Translational perspective on epigenetics in cardiovascular disease. J Am Coll Cardiol. 2017;70(5):590–606.CrossRefPubMed van der Harst P, de Windt LJ, Chambers JC. Translational perspective on epigenetics in cardiovascular disease. J Am Coll Cardiol. 2017;70(5):590–606.CrossRefPubMed
6.
go back to reference Ehret GB. Genome-wide association studies: contribution of genomics to understanding blood pressure and essential hypertension. Curr Hypertens Rep. 2010;12(1):17–25.CrossRefPubMedPubMedCentral Ehret GB. Genome-wide association studies: contribution of genomics to understanding blood pressure and essential hypertension. Curr Hypertens Rep. 2010;12(1):17–25.CrossRefPubMedPubMedCentral
7.
go back to reference Levy D, Ehret GB, Rice K, Verwoert GC, Launer LJ, Dehghan A, et al. Genome-wide association study of blood pressure and hypertension. Nat Genet. 2009;41(6):677–87.CrossRefPubMedPubMedCentral Levy D, Ehret GB, Rice K, Verwoert GC, Launer LJ, Dehghan A, et al. Genome-wide association study of blood pressure and hypertension. Nat Genet. 2009;41(6):677–87.CrossRefPubMedPubMedCentral
8.
go back to reference Fu Z, Nakayama T, Sato N, Izumi Y, Kasamaki Y, Shindo A, et al. Haplotype-based case-control study of the human CYP4F2 gene and essential hypertension in Japanese subjects. Hypertens Res. 2008a;31(9):1719–26.CrossRefPubMed Fu Z, Nakayama T, Sato N, Izumi Y, Kasamaki Y, Shindo A, et al. Haplotype-based case-control study of the human CYP4F2 gene and essential hypertension in Japanese subjects. Hypertens Res. 2008a;31(9):1719–26.CrossRefPubMed
9.
go back to reference Yu C, Yan Q, Fu C, Shi W, Wang H, Zeng C, et al. CYP4F2 genetic polymorphisms are associated with coronary heart disease in a Chinese population. Lipids Health Dis. 2014;13:83.CrossRefPubMedPubMedCentral Yu C, Yan Q, Fu C, Shi W, Wang H, Zeng C, et al. CYP4F2 genetic polymorphisms are associated with coronary heart disease in a Chinese population. Lipids Health Dis. 2014;13:83.CrossRefPubMedPubMedCentral
10.
go back to reference Waldman M, Peterson SJ, Arad M, Hochhauser E. The role of 20-HETE in cardiovascular diseases and its risk factors. Prostaglandins Other Lipid Mediat. 2016;125:108–17.CrossRefPubMed Waldman M, Peterson SJ, Arad M, Hochhauser E. The role of 20-HETE in cardiovascular diseases and its risk factors. Prostaglandins Other Lipid Mediat. 2016;125:108–17.CrossRefPubMed
11.
13.
go back to reference Luo XH, Li GR, Li HY. Association of the CYP4F2 rs2108622 genetic polymorphism with hypertension: a meta-analysis. Genet Mol Res. 2015;14(4):15133–9.CrossRefPubMed Luo XH, Li GR, Li HY. Association of the CYP4F2 rs2108622 genetic polymorphism with hypertension: a meta-analysis. Genet Mol Res. 2015;14(4):15133–9.CrossRefPubMed
14.
go back to reference Meng C, Wang J, Ge WN, Tang SC, Xu GM. Correlation between CYP4F2 gene rs2108622 polymorphism and susceptibility to ischemic stroke. Int J Clin Exp Med. 2015;8(9):16122–6.PubMedPubMedCentral Meng C, Wang J, Ge WN, Tang SC, Xu GM. Correlation between CYP4F2 gene rs2108622 polymorphism and susceptibility to ischemic stroke. Int J Clin Exp Med. 2015;8(9):16122–6.PubMedPubMedCentral
15.
go back to reference Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.CrossRefPubMedPubMedCentral Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.CrossRefPubMedPubMedCentral
16.
go back to reference Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5.CrossRefPubMed Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5.CrossRefPubMed
17.
go back to reference Dan SL, Lin RY, Zou XX. Association of CYP4F2 gene polymorphism and haplotypes with coronary heart disease in Chongqing Han. Chin J Geriatr Heart Brain Ves Dis. 2009;11(7):505–8. Dan SL, Lin RY, Zou XX. Association of CYP4F2 gene polymorphism and haplotypes with coronary heart disease in Chongqing Han. Chin J Geriatr Heart Brain Ves Dis. 2009;11(7):505–8.
18.
go back to reference Deng SM. Effect of polymorphisms of CYP4F2, CYP4A11 and LTC4S gene on ischemic stroke. China Medical University. 2010;38–43. Deng SM. Effect of polymorphisms of CYP4F2, CYP4A11 and LTC4S gene on ischemic stroke. China Medical University. 2010;38–43.
19.
go back to reference Fan CH, He QF, Yu M, Chen ZK, Zhong YH. Association between genetic polymorphisms of CYP4F2 and susceptibility of essential hypertension. Zhejiang Med J. 2011;33(12):1732–4. Fan CH, He QF, Yu M, Chen ZK, Zhong YH. Association between genetic polymorphisms of CYP4F2 and susceptibility of essential hypertension. Zhejiang Med J. 2011;33(12):1732–4.
20.
go back to reference Fava C, Montagnana M, Almgren P, Rosberg L, Lippi G, Hedblad B, et al. The V433M variant of the CYP4F2 is associated with ischemic stroke in male swedes beyond its effect on blood pressure. Hypertension. 2008;52(2):373–80.CrossRefPubMed Fava C, Montagnana M, Almgren P, Rosberg L, Lippi G, Hedblad B, et al. The V433M variant of the CYP4F2 is associated with ischemic stroke in male swedes beyond its effect on blood pressure. Hypertension. 2008;52(2):373–80.CrossRefPubMed
21.
go back to reference Fu Z, Nakayama T, Sato N, Izumi Y, Kasamaki Y, Shindo A, et al. A haplotype of the CYP4F2 gene is associated with cerebral infarction in Japanese men. Am J Hypertens. 2008b;21(11):1216–23.CrossRefPubMed Fu Z, Nakayama T, Sato N, Izumi Y, Kasamaki Y, Shindo A, et al. A haplotype of the CYP4F2 gene is associated with cerebral infarction in Japanese men. Am J Hypertens. 2008b;21(11):1216–23.CrossRefPubMed
22.
go back to reference Huang D, Fu ZY, Yang YN, Xie X, Wang YH, Ma YT. Association on the haplotypes of CYP4F2 gene and myocardial infarction. Zhonghua Liu Xing Bing Xue Za Zhi. 2009;30(7):733–6.PubMed Huang D, Fu ZY, Yang YN, Xie X, Wang YH, Ma YT. Association on the haplotypes of CYP4F2 gene and myocardial infarction. Zhonghua Liu Xing Bing Xue Za Zhi. 2009;30(7):733–6.PubMed
23.
go back to reference Li M, Wang H, Liu JL, Wang LJ, Zhang B, Liu Y, et al. Association of rs2108622 polymorphism of CYP4F2 gene and essential hypertension in the northern Han Chinese. Journal of cardiovascular and pulmonary. Diseases. 2013;32(5):538–42. Li M, Wang H, Liu JL, Wang LJ, Zhang B, Liu Y, et al. Association of rs2108622 polymorphism of CYP4F2 gene and essential hypertension in the northern Han Chinese. Journal of cardiovascular and pulmonary. Diseases. 2013;32(5):538–42.
24.
go back to reference Liao D, Yi X, Zhang B, Zhou Q, Lin J. Interaction between CYP4F2 rs2108622 and CPY4A11 rs9333025 variants is significantly correlated with susceptibility to ischemic stroke and 20-Hydroxyeicosatetraenoic acid level. Genet Test Mol Biomarkers. 2016;20(5):223–8.CrossRefPubMedPubMedCentral Liao D, Yi X, Zhang B, Zhou Q, Lin J. Interaction between CYP4F2 rs2108622 and CPY4A11 rs9333025 variants is significantly correlated with susceptibility to ischemic stroke and 20-Hydroxyeicosatetraenoic acid level. Genet Test Mol Biomarkers. 2016;20(5):223–8.CrossRefPubMedPubMedCentral
25.
go back to reference Liu JH. Association of CYP4A11 and CYP4F2 polymorphism with essential hypertension and coronary heart disease. Southern Medical University. 2012;62–8. Liu JH. Association of CYP4A11 and CYP4F2 polymorphism with essential hypertension and coronary heart disease. Southern Medical University. 2012;62–8.
26.
go back to reference Munshi A, Sharma V, Kaul S, Al-Hazzani A, Alshatwi AA, Shafi G, et al. Association of 1347 G/a cytochrome P450 4F2 (CYP4F2) gene variant with hypertension and stroke. Mol Biol Rep. 2012;39(2):1677–82.CrossRefPubMed Munshi A, Sharma V, Kaul S, Al-Hazzani A, Alshatwi AA, Shafi G, et al. Association of 1347 G/a cytochrome P450 4F2 (CYP4F2) gene variant with hypertension and stroke. Mol Biol Rep. 2012;39(2):1677–82.CrossRefPubMed
27.
go back to reference Wang F. Effect of common polymorphisms in CYP4A11, CYP4F2 genes on the presence of essential hypertension. Ningbo University. 2012;9–20. Wang F. Effect of common polymorphisms in CYP4A11, CYP4F2 genes on the presence of essential hypertension. Ningbo University. 2012;9–20.
28.
go back to reference Wang XH, Zhang WK, Fu W, Cao HK. Study of the correlation between the gene polymorphism of CYP4F2 and coronary heart disease in Yunnan Han population. Journal of Bengbu Medical College. 2017;42(5):565–7. Wang XH, Zhang WK, Fu W, Cao HK. Study of the correlation between the gene polymorphism of CYP4F2 and coronary heart disease in Yunnan Han population. Journal of Bengbu Medical College. 2017;42(5):565–7.
29.
go back to reference Ward NC, Tsai IJ, Barden A, van Bockxmeer FM, Puddey IB, Hodgson JM, et al. A single nucleotide polymorphism in the CYP4F2 but not CYP4A11 gene is associated with increased 20-HETE excretion and blood pressure. Hypertension. 2008;51(5):1393–8.CrossRefPubMed Ward NC, Tsai IJ, Barden A, van Bockxmeer FM, Puddey IB, Hodgson JM, et al. A single nucleotide polymorphism in the CYP4F2 but not CYP4A11 gene is associated with increased 20-HETE excretion and blood pressure. Hypertension. 2008;51(5):1393–8.CrossRefPubMed
30.
go back to reference Yan HQ, Yuan Y, Zhang P, Huang Z, Chang L, Gui YK. CYP4F2 gene single nucleotide polymorphism is associated with ischemic stroke. Genet Mol Res. 2015;14(1):659–64.CrossRefPubMed Yan HQ, Yuan Y, Zhang P, Huang Z, Chang L, Gui YK. CYP4F2 gene single nucleotide polymorphism is associated with ischemic stroke. Genet Mol Res. 2015;14(1):659–64.CrossRefPubMed
31.
go back to reference Yang H. Association study of haplotypes of the CYP gene and sex hormone with coronary heart disease. Master: Xinjiang Medical University; 2013. Yang H. Association study of haplotypes of the CYP gene and sex hormone with coronary heart disease. Master: Xinjiang Medical University; 2013.
32.
go back to reference Zhang LX, Yang J, Chen FF, Wang DW. Association between the G20597A variant of CYP4F2 gene and essential hypertension. J Chin Physician. 2010;12(1):27–30. Zhang LX, Yang J, Chen FF, Wang DW. Association between the G20597A variant of CYP4F2 gene and essential hypertension. J Chin Physician. 2010;12(1):27–30.
33.
go back to reference Zhao P, Chang PY, Jiang K, Ge RL. The association between CYP4F2 gene polymorphism and coronary heart disease. Chin J Gerontol. 2017;37(15):3703–5. Zhao P, Chang PY, Jiang K, Ge RL. The association between CYP4F2 gene polymorphism and coronary heart disease. Chin J Gerontol. 2017;37(15):3703–5.
34.
go back to reference Zhao P, Chang PY, Nan JL, Jiang P, Ge RL, Xie JM. Research for correlation between CYP4F2 gene polymorphism and coronary heart disease in Mongolian patients. Chinese Journal of cardiovascular Rehabilitation Medicine. 2016;25(1):18–21. Zhao P, Chang PY, Nan JL, Jiang P, Ge RL, Xie JM. Research for correlation between CYP4F2 gene polymorphism and coronary heart disease in Mongolian patients. Chinese Journal of cardiovascular Rehabilitation Medicine. 2016;25(1):18–21.
35.
go back to reference Sayols-Baixeras S, Lluis-Ganella C, Lucas G, Elosua R. Pathogenesis of coronary artery disease: focus on genetic risk factors and identification of genetic variants. Appl Clin Genet. 2014;7:15–32.PubMedPubMedCentral Sayols-Baixeras S, Lluis-Ganella C, Lucas G, Elosua R. Pathogenesis of coronary artery disease: focus on genetic risk factors and identification of genetic variants. Appl Clin Genet. 2014;7:15–32.PubMedPubMedCentral
36.
go back to reference Stec DE, Roman RJ, Flasch A, Rieder MJ. Functional polymorphism in human CYP4F2 decreases 20-HETE production. Physiol Genomics. 2007;30(1):74–81.CrossRefPubMed Stec DE, Roman RJ, Flasch A, Rieder MJ. Functional polymorphism in human CYP4F2 decreases 20-HETE production. Physiol Genomics. 2007;30(1):74–81.CrossRefPubMed
37.
go back to reference Cassella CR, Jagoda A. Ischemic stroke: advances in diagnosis and management. Emerg Med Clin North Am. 2017;35(4):911–30.CrossRefPubMed Cassella CR, Jagoda A. Ischemic stroke: advances in diagnosis and management. Emerg Med Clin North Am. 2017;35(4):911–30.CrossRefPubMed
38.
go back to reference Ding H, Cui G, Zhang L, Xu Y, Bao X, Tu Y, et al. Association of common variants of CYP4A11 and CYP4F2 with stroke in the Han Chinese population. Pharmacogenet Genomics. 2010;20(3):187–94.CrossRefPubMedPubMedCentral Ding H, Cui G, Zhang L, Xu Y, Bao X, Tu Y, et al. Association of common variants of CYP4A11 and CYP4F2 with stroke in the Han Chinese population. Pharmacogenet Genomics. 2010;20(3):187–94.CrossRefPubMedPubMedCentral
39.
go back to reference Jokinen E. Obesity and cardiovascular disease. Minerva Pediatr. 2015;67(1):25–32.PubMed Jokinen E. Obesity and cardiovascular disease. Minerva Pediatr. 2015;67(1):25–32.PubMed
Metadata
Title
Cytochrome P450 family 4 subfamily F member 2 (CYP4F2) rs1558139, rs2108622 polymorphisms and susceptibility to several cardiovascular and cerebrovascular diseases
Authors
Tao Zhang
Kuiying Yu
Xuhua Li
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2018
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-018-0763-y

Other articles of this Issue 1/2018

BMC Cardiovascular Disorders 1/2018 Go to the issue